Literature DB >> 23001239

Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010.

Jennifer L Moss1, Melissa B Gilkey, Paul L Reiter, Noel T Brewer.   

Abstract

BACKGROUND: To better target future immunization efforts, we assessed trends and disparities in human papillomavirus (HPV) vaccine initiation among female adolescents in North Carolina over 3 years.
METHODS: We analyzed data from a stratified random sample of 1,427 parents who, between 2008 and 2010, completed two linked telephone surveys: the Behavioral Risk Factor Surveillance System and the Child Health Assessment and Monitoring Program surveys. Weighted analyses examined HPV vaccine initiation for girls ages 11 to 17 years.
RESULTS: HPV vaccine initiation increased modestly over time (2008, 34%; 2009, 41%; 2010, 44%). This upward trend was present within 11 subpopulations of girls, including those who lived in rural areas, were of minority (non-black/non-white) race, or had not recently received a preventive check-up. Looking at differences between groups, HPV vaccine initiation was less common among girls who attended private versus public school, were younger, or lacked a recent check-up. However, the latter difference narrowed over time. The low level of initiation among girls without recent check-ups increased substantially (from 11% to 41%), whereas initiation among girls with recent visits improved little (from 39% to 44%, P(interaction) = 0.007).
CONCLUSIONS: Although HPV vaccine initiation improved among several groups typically at higher risk for cervical cancer, the lack of progress among girls with recent check-ups suggests that missed opportunities for administration have hampered broader improvements. IMPACT: Achieving widespread coverage of HPV vaccine will require redoubled efforts to vaccinate adolescents during routine care. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001239      PMCID: PMC3712347          DOI: 10.1158/1055-9965.EPI-12-0509

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

Review 1.  Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services.

Authors:  P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams
Journal:  Am J Prev Med       Date:  2000-01       Impact factor: 5.043

2.  Human papillomavirus vaccine should be given before sexual debut for maximum benefit.

Authors:  Allan Hildesheim; Rolando Herrero
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

3.  National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-31       Impact factor: 17.586

4.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

5.  Burden of cervical cancer in the United States, 1998-2003.

Authors:  Meg Watson; Mona Saraiya; Vicki Benard; Steven S Coughlin; Lisa Flowers; Vilma Cokkinides; Molly Schwenn; Youjie Huang; Anna Giuliano
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

6.  Adolescent immunizations: missed opportunities for prevention.

Authors:  Grace M Lee; Suchita A Lorick; Elizabeth Pfoh; Ken Kleinman; Daniel Fishbein
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

7.  The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening.

Authors:  Kristjan Sigurdsson; Helgi Sigvaldason; Thorbjorg Gudmundsdottir; Rafn Sigurdsson; Haraldur Briem
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

8.  Health and economic implications of HPV vaccination in the United States.

Authors:  Jane J Kim; Sue J Goldie
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

Review 9.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

10.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors:  L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

View more
  19 in total

1.  Racial disparities in human papillomavirus vaccination: does access matter?

Authors:  Amanda Gelman; Elizabeth Miller; Eleanor Bimla Schwarz; Aletha Y Akers; Kwonho Jeong; Sonya Borrero
Journal:  J Adolesc Health       Date:  2013-08-27       Impact factor: 5.012

2.  Challenges of using nationally representative, population-based surveys to assess rural cancer disparities.

Authors:  Whitney E Zahnd; Natoshia Askelson; Robin C Vanderpool; Lindsay Stradtman; Jean Edward; Paige E Farris; Victoria Petermann; Jan M Eberth
Journal:  Prev Med       Date:  2019-08-15       Impact factor: 4.018

3.  Initiation of Human Papillomavirus Vaccination Among Predominantly Minority Female and Male Adolescents at Inner-City Community Health Centers.

Authors:  Rula M Btoush; Diane R Brown; Sushanna Fogarty; Dennis P Carmody
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

4.  Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females.

Authors:  Paul L Reiter; Kunal Gupta; Noel T Brewer; Melissa B Gilkey; Mira L Katz; Electra D Paskett; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-14       Impact factor: 4.254

5.  Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.

Authors:  Shannon M Monnat; Danielle C Rhubart; Sherrie Flynt Wallington
Journal:  Matern Child Health J       Date:  2016-02

6.  HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center.

Authors:  Rula M Wilson; Diane R Brown; Dennis P Carmody; Sushanna Fogarty
Journal:  J Community Health       Date:  2015-06

7.  Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination.

Authors:  Jennifer L Moss; Melissa B Gilkey; Barbara K Rimer; Noel T Brewer
Journal:  Hum Vaccin Immunother       Date:  2016-01-19       Impact factor: 3.452

8.  Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents.

Authors:  Stephanie A S Staras; Susan T Vadaparampil; Melvin D Livingston; Lindsay A Thompson; Ashley H Sanders; Elizabeth A Shenkman
Journal:  J Adolesc Health       Date:  2015-05       Impact factor: 5.012

9.  Collaborative patient-provider communication and uptake of adolescent vaccines.

Authors:  Jennifer L Moss; Paul L Reiter; Barbara K Rimer; Noel T Brewer
Journal:  Soc Sci Med       Date:  2016-04-25       Impact factor: 4.634

10.  Ranking States on Coverage of Cancer-Preventing Vaccines Among Adolescents: The Influence of Imprecision.

Authors:  Anne R Waldrop; Jennifer L Moss; Benmei Liu; Li Zhu
Journal:  Public Health Rep       Date:  2017-08-30       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.